ALLO Competitors & Alternatives

Compare Allogene Therapeutics Inc with similar stocks in the same industry

Biotechnology

ALLO

Main Stock
$1.88
Tradestie Score
50
Market Cap
$275.13M
Revenue Growth
-1.0%
Analyst Upside
+378.7%

Top Competitors

232 stocks in Biotechnology
Company Price Market Cap P/E Score Action
TBPH Theravance Biopharma, Inc.
$16.86
$726.21M 7.6 54 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$23.21
$718.62M - 60 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$31.88
$715.25M - 46 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
$704.73M - 59 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$139.04
$699.30M - 51 Compare
GYRE Gyre Therapeutics, Inc. Common Stock
$5.75
$688.47M - 45 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
$683.46M - 57 Compare
ARVN Arvinas, Inc
$8.03
$670.30M - 54 Compare
MGTX MeiraGTx Holdings plc Ordinary Shares
$11.79
$665.30M - 58 Compare
MPLT MPLT
$13.02
$636.20M - 51 Compare

Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)

232 stocks in this industry